Eric K. Nicholson

Array ( [id] => 10548523 [patent_doc_number] => 09273134 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-03-01 [patent_title] => 'Inhibitors of receptor tyrosine kinases and methods of use thereof' [patent_app_type] => utility [patent_app_number] => 12/602235 [patent_app_country] => US [patent_app_date] => 2008-06-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 53 [patent_figures_cnt] => 63 [patent_no_of_words] => 68951 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 82 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12602235 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7515364 [patent_doc_number] => 08039436 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-10-18 [patent_title] => 'Mutated HOXB4 proteins with improved stability, and methods of use thereof' [patent_app_type] => utility [patent_app_number] => 12/129919 [patent_app_country] => US [patent_app_date] => 2008-05-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 28 [patent_figures_cnt] => 26 [patent_no_of_words] => 16112 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 127 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/039/08039436.pdf [firstpage_image] =>[orig_patent_app_number] => 12129919 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7587523 [patent_doc_number] => 20110282033 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-11-17 [patent_title] => 'AMINO ACID SEQUENCES DIRECTED AGAINST GROWTH FACTOR RECEPTORS AND POLYPEPTIDES COMPRISING THE SAME FOR THE TREATMENT OF DISEASES AND DISORDERS ASSOCIATED WITH GROWTH FACTORS AND THEIR RECEPTORS' [patent_app_type] => utility [patent_app_number] => 12/600023 [patent_app_country] => US [patent_app_date] => 2008-05-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 87826 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0282/20110282033.pdf [firstpage_image] =>[orig_patent_app_number] => 12600023 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6266399 [patent_doc_number] => 20100298217 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-11-25 [patent_title] => 'CSF-1R MUTANTS' [patent_app_type] => utility [patent_app_number] => 12/451680 [patent_app_country] => US [patent_app_date] => 2008-05-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 20 [patent_no_of_words] => 11298 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0298/20100298217.pdf [firstpage_image] =>[orig_patent_app_number] => 12451680 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5349395 [patent_doc_number] => 20090004756 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-01-01 [patent_title] => 'METHODS FOR IDENTIFYING AGENTS THAT TARGET LEAKS IN RYANODINE RECEPTORS' [patent_app_type] => utility [patent_app_number] => 12/121446 [patent_app_country] => US [patent_app_date] => 2008-05-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7326 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0004/20090004756.pdf [firstpage_image] =>[orig_patent_app_number] => 12121446 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6581040 [patent_doc_number] => 20100291073 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-11-18 [patent_title] => 'METHODS OF REDUCING EOSINOPHIL LEVELS' [patent_app_type] => utility [patent_app_number] => 12/600017 [patent_app_country] => US [patent_app_date] => 2008-05-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 48 [patent_figures_cnt] => 48 [patent_no_of_words] => 33012 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0291/20100291073.pdf [firstpage_image] =>[orig_patent_app_number] => 12600017 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6391809 [patent_doc_number] => 20100303802 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-12-02 [patent_title] => 'ANTIBODY DIRECTED TO G PROTEIN COUPLED RECEPTORS (GPCR)' [patent_app_type] => utility [patent_app_number] => 12/599698 [patent_app_country] => US [patent_app_date] => 2008-05-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 6021 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0303/20100303802.pdf [firstpage_image] =>[orig_patent_app_number] => 12599698 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5273905 [patent_doc_number] => 20090077681 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-03-19 [patent_title] => 'Methods for Diagnosing and Treating Heart Disease' [patent_app_type] => utility [patent_app_number] => 12/115986 [patent_app_country] => US [patent_app_date] => 2008-05-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 12213 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0077/20090077681.pdf [firstpage_image] =>[orig_patent_app_number] => 12115986 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9153628 [patent_doc_number] => 08586534 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-11-19 [patent_title] => 'Intracellular domain of a mammalian Fat1 (Fat1IC)' [patent_app_type] => utility [patent_app_number] => 12/150176 [patent_app_country] => US [patent_app_date] => 2008-04-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 14774 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 87 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12150176 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5944091 [patent_doc_number] => 20110104711 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-05-05 [patent_title] => 'GPR81-Ligand complexes and their preparation and use' [patent_app_type] => utility [patent_app_number] => 12/080448 [patent_app_country] => US [patent_app_date] => 2008-04-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 22 [patent_no_of_words] => 10610 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0104/20110104711.pdf [firstpage_image] =>[orig_patent_app_number] => 12080448 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6136230 [patent_doc_number] => 20110009328 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-01-13 [patent_title] => 'Polypeptide Derivatives of Parathyroid Hormone (PTH)' [patent_app_type] => utility [patent_app_number] => 12/053149 [patent_app_country] => US [patent_app_date] => 2008-03-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 23979 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 21 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0009/20110009328.pdf [firstpage_image] =>[orig_patent_app_number] => 12053149 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9607972 [patent_doc_number] => 08785135 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-07-22 [patent_title] => 'Mutant G-protein coupled receptors and methods for selecting them' [patent_app_type] => utility [patent_app_number] => 12/450358 [patent_app_country] => US [patent_app_date] => 2008-03-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 35 [patent_figures_cnt] => 45 [patent_no_of_words] => 28144 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 277 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12450358 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5337275 [patent_doc_number] => 20090053739 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-02-26 [patent_title] => 'Ligand for G-protein coupled receptor FPRL2 and uses thereof' [patent_app_type] => utility [patent_app_number] => 12/075849 [patent_app_country] => US [patent_app_date] => 2008-03-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 24 [patent_figures_cnt] => 24 [patent_no_of_words] => 37966 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0053/20090053739.pdf [firstpage_image] =>[orig_patent_app_number] => 12075849 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6488589 [patent_doc_number] => 20100009406 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-01-14 [patent_title] => 'Nucleic acids encoding a heme binding protein polypeptide' [patent_app_type] => utility [patent_app_number] => 12/075971 [patent_app_country] => US [patent_app_date] => 2008-03-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 22 [patent_no_of_words] => 37959 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0009/20100009406.pdf [firstpage_image] =>[orig_patent_app_number] => 12075971 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4718637 [patent_doc_number] => 20080241159 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-10-02 [patent_title] => 'METHODS AND COMPOSITIONS FOR SELECTIVE MODULATION OF VASCULARIZATION' [patent_app_type] => utility [patent_app_number] => 12/046795 [patent_app_country] => US [patent_app_date] => 2008-03-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 18800 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0241/20080241159.pdf [firstpage_image] =>[orig_patent_app_number] => 12046795 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6317190 [patent_doc_number] => 20100112617 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-05-06 [patent_title] => 'Evaluating RTK Target Drugs' [patent_app_type] => utility [patent_app_number] => 12/532396 [patent_app_country] => US [patent_app_date] => 2008-03-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 3202 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0112/20100112617.pdf [firstpage_image] =>[orig_patent_app_number] => 12532396 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10567386 [patent_doc_number] => 09290543 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-03-22 [patent_title] => 'Compositions and methods for the therapy and diagnosis of inflammatory bowel disease' [patent_app_type] => utility [patent_app_number] => 12/036588 [patent_app_country] => US [patent_app_date] => 2008-02-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 41672 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 170 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12036588 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4719438 [patent_doc_number] => 20080241961 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-10-02 [patent_title] => 'DROSOPHILA G PROTEIN COUPLED RECEPTORS, NUCLEIC ACIDS, AND MEHTODS RELATED TO THE SAME' [patent_app_type] => utility [patent_app_number] => 12/032029 [patent_app_country] => US [patent_app_date] => 2008-02-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 36553 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0241/20080241961.pdf [firstpage_image] =>[orig_patent_app_number] => 12032029 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6465062 [patent_doc_number] => 20100190701 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-07-29 [patent_title] => 'GLUCAGON/GLP-1 RECEPTOR CO-AGONISTS' [patent_app_type] => utility [patent_app_number] => 12/527140 [patent_app_country] => US [patent_app_date] => 2008-02-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 24 [patent_figures_cnt] => 24 [patent_no_of_words] => 34095 [patent_no_of_claims] => 36 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0190/20100190701.pdf [firstpage_image] =>[orig_patent_app_number] => 12527140 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5545295 [patent_doc_number] => 20090155172 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-06-18 [patent_title] => 'Antibodies to MAGMAS and uses thereof' [patent_app_type] => utility [patent_app_number] => 12/020524 [patent_app_country] => US [patent_app_date] => 2008-01-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 23414 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0155/20090155172.pdf [firstpage_image] =>[orig_patent_app_number] => 12020524 [rel_patent_id] =>[rel_patent_doc_number] =>)